Documents & Downloads

Thalidasine

Anticancer Agent

Thalidasine, a bisbenzyltetrahydroisoquinoline alkaloid, is recognized for its anticancer activity, specifically targeting human colon adenocarcinoma cells. Additionally, Thalidasine demonstrates potent antileishmanial properties, making it a valuable compound for research on Leishmania infections. Its dual functionality in cancer and infectious disease models positions Thalidasine as a useful reagent for scientists investigating therapeutic strategies in these areas.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	16623-56-6
Applications	Anticancer Agent
Formula	C₃₉H₄₄N₂O₇
Molecular Weight	652.78
SMILES	COC1=CC(CCN2C)=C(C(OC3=C(OC)C(OC)=CC4=C3CCN(C)[C@H]4CC5=CC=C(O6)C=C5)=C1OC)[C@@H]2CC7=CC=C(OC)C6=C7

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.